Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Disease-causing Mitochondrial Heteroplasmy Segregated within Induced Pluripotent Stem Cell Clones Derived from A MELAS Patient.
Folmes CD, Martinez-Fernandez A, Perales-Clemente E, Li X, McDonald A, Oglesbee D, Hrstka SC, Perez-Terzic C, Terzic A, Nelson TJ.
Stem Cells. 2013 Apr 3. doi: 10.1002/stem.1389. [Epub ahead of print]
Related citations
Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.
Folmes CD, Martinez-Fernandez A, Faustino RS, Yamada S, Perez-Terzic C, Nelson TJ, Terzic A.
J Cardiovasc Transl Res. 2013 Feb;6(1):10-21. doi: 10.1007/s12265-012-9431-2. Epub 2012 Dec 18.
Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk.
Smith AJ, Nelson NG, Oommen S, Hartjes KA, Folmes CD, Terzic A, Nelson TJ.
Stem Cells Transl Med. 2012 Oct;1(10):709-18. doi: 10.5966/sctm.2012-0066. Epub 2012 Sep 27.
Metabolic plasticity in stem cell homeostasis and differentiation.
Folmes CD, Dzeja PP, Nelson TJ, Terzic A.
Cell Stem Cell. 2012 Nov 2;11(5):596-606. doi: 10.1016/j.stem.2012.10.002.
Energy metabolism plasticity enables stemness programs.
Folmes CD, Nelson TJ, Dzeja PP, Terzic A.
Ann N Y Acad Sci. 2012 Apr;1254:82-9. doi: 10.1111/j.1749-6632.2012.06487.x. Review.
Mitochondria in control of cell fate.
Circ Res. 2012 Feb 17;110(4):526-9. doi: 10.1161/RES.0b013e31824ae5c1. No abstract available.
Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming.
Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A.
Cell Metab. 2011 Aug 3;14(2):264-71. doi: 10.1016/j.cmet.2011.06.011.
The science and ethics of induced pluripotency: what will become of embryonic stem cells?
Zacharias DG, Nelson TJ, Mueller PS, Hook CC.
Mayo Clin Proc. 2011 Jul;86(7):634-40. doi: 10.4065/mcp.2011.0054.
Regenerative medicine: a reality of stem cell technology.
Terzic A, Edwards BS, McKee KC, Nelson TJ.
Minn Med. 2011 May;94(5):44-7.
Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells.
Martinez-Fernandez A, Nelson TJ, Terzic A.
J Cardiovasc Transl Res. 2011 Apr;4(2):131-7. doi: 10.1007/s12265-010-9250-2. Epub 2011 Jan 5. Review.
Induced pluripotent stem cells: advances to applications.
Nelson TJ, Martinez-Fernandez A, Yamada S, Ikeda Y, Perez-Terzic C, Terzic A.
Stem Cells Cloning. 2010 Jan 1;3:29-37.
Induced pluripotent stem cells: developmental biology to regenerative medicine.
Nelson TJ, Martinez-Fernandez A, Terzic A.
Nat Rev Cardiol. 2010 Dec;7(12):700-10. doi: 10.1038/nrcardio.2010.159. Epub 2010 Oct 19. Review.
SDF-1-enhanced cardiogenesis requires CXCR4 induction in pluripotent stem cells.
Chiriac A, Terzic A, Park S, Ikeda Y, Faustino R, Nelson TJ.
J Cardiovasc Transl Res. 2010 Dec;3(6):674-82. doi: 10.1007/s12265-010-9219-1. Epub 2010 Sep 15.
Stem cells: clinical trials results the end of the beginning or the beginning of the end?
Behfar A, Crespo-Diaz R, Nelson TJ, Terzic A, Gersh BJ.
Cardiovasc Hematol Disord Drug Targets. 2010 Sep 1;10(3):186-201. Review.
ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy.
Zlatkovic-Lindor J, Arrell DK, Yamada S, Nelson TJ, Terzic A.
Stem Cells. 2010 Aug;28(8):1355-67. doi: 10.1002/stem.465.
Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype.
Faustino RS, Chiriac A, Niederlander NJ, Nelson TJ, Behfar A, Mishra PK, Macura S, Michalak M, Terzic A, Perez-Terzic C.
Stem Cells. 2010 Jul;28(7):1281-91. doi: 10.1002/stem.447.
Cardiogenic induction of pluripotent stem cells streamlined through a conserved SDF-1/VEGF/BMP2 integrated network.
Chiriac A, Nelson TJ, Faustino RS, Behfar A, Terzic A.
PLoS One. 2010 Apr 1;5(4):e9943. doi: 10.1371/journal.pone.0009943.
c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A, Nelson TJ, Ikeda Y, Terzic A.
J Cardiovasc Transl Res. 2010 Feb;3(1):13-23. doi: 10.1007/s12265-009-9150-5.
Induced pluripotent reprogramming from promiscuous human stemness related factors.
Nelson TJ, Martinez-Fernandez A, Yamada S, Mael AA, Terzic A, Ikeda Y.
Clin Transl Sci. 2009 Apr;2(2):118-26. doi: 10.1111/j.1752-8062.2009.00091.x.
Stem cell platforms for regenerative medicine.
Nelson TJ, Behfar A, Yamada S, Martinez-Fernandez A, Terzic A.
Clin Transl Sci. 2009 Jun;2(3):222-7. doi: 10.1111/j.1752-8062.2009.00096.x.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on